Dietary spermidine improves cognitive function.
Aging
/ genetics
Animals
Autophagy-Related Protein 7
/ genetics
Brain
/ cytology
Cognition
/ drug effects
Cognitive Dysfunction
/ genetics
Dietary Supplements
Drosophila melanogaster
/ drug effects
Female
Gene Expression Regulation
Humans
Learning
/ drug effects
Male
Mice
Mitochondria
/ drug effects
Neurons
/ drug effects
Oxidative Phosphorylation
/ drug effects
Protein Kinases
/ genetics
Signal Transduction
Spatial Memory
/ drug effects
Spermidine
/ pharmacology
Ubiquitin-Protein Ligases
/ genetics
Pink1
aging
autophagy
cognitive function
dietary spermidine
memory
mitochondria
mitophagy
Journal
Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691
Informations de publication
Date de publication:
13 04 2021
13 04 2021
Historique:
received:
03
06
2019
revised:
08
02
2021
accepted:
22
03
2021
entrez:
14
4
2021
pubmed:
15
4
2021
medline:
15
2
2022
Statut:
ppublish
Résumé
Decreased cognitive performance is a hallmark of brain aging, but the underlying mechanisms and potential therapeutic avenues remain poorly understood. Recent studies have revealed health-protective and lifespan-extending effects of dietary spermidine, a natural autophagy-promoting polyamine. Here, we show that dietary spermidine passes the blood-brain barrier in mice and increases hippocampal eIF5A hypusination and mitochondrial function. Spermidine feeding in aged mice affects behavior in homecage environment tasks, improves spatial learning, and increases hippocampal respiratory competence. In a Drosophila aging model, spermidine boosts mitochondrial respiratory capacity, an effect that requires the autophagy regulator Atg7 and the mitophagy mediators Parkin and Pink1. Neuron-specific Pink1 knockdown abolishes spermidine-induced improvement of olfactory associative learning. This suggests that the maintenance of mitochondrial and autophagic function is essential for enhanced cognition by spermidine feeding. Finally, we show large-scale prospective data linking higher dietary spermidine intake with a reduced risk for cognitive impairment in humans.
Identifiants
pubmed: 33852843
pii: S2211-1247(21)00299-0
doi: 10.1016/j.celrep.2021.108985
pii:
doi:
Substances chimiques
Ubiquitin-Protein Ligases
EC 2.3.2.27
parkin protein
EC 2.3.2.27
Protein Kinases
EC 2.7.-
PTEN-induced putative kinase
EC 2.7.11.1
ATG7 protein, human
EC 6.2.1.45
Autophagy-Related Protein 7
EC 6.2.1.45
Spermidine
U87FK77H25
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
108985Subventions
Organisme : Austrian Science Fund FWF
ID : W 1226
Pays : Austria
Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests F.M., S.J.S., and D.C.-G. have equity interests in The Longevity Labs (TLL), a company founded in 2016 that develops natural food extracts. T.E. has equity interests in and conducts paid consultancies for TLL. G.K. holds research contracts with Bayer Healthcare, Genentech, GlaxoSmithKline, Institut Mérieux, Kaleido Biosciences, Lytix Biopharma, NuCana, Oncolinx, PharmaMar, Samsara Therapeutics, SOTIO, and Tioma Therapeutics. G.K. is on the Board of Directors of the Bristol Myers Squibb Foundation France. G.K. is a scientific cofounder of everImmune, a biotech company that develops immunostimulatory bacteria, and Therafast Bio. F.M. and T.E. are inventors on a pending patent application related to this work.